摘要
目的探讨重症急性胰腺炎(SAP)患者脂联素、TNF-α和CRP水平的变化特点及连续性肾脏替代疗法(CRRT)对其影响。方法按照平行对照设计原理,将所有66例患者分为对照组和CRRT组。对两组患者的相关临床资料及脂联素、TNF-α和CRP水平进行比较。结果与CRRT组患者比较,对照组患者第1天TNF-α和CRP水平均明显升高(均P〈0.05),脂联素水平明显降低(P〈0.05);与CRRT组患者比较,对照组患者第2、3天TNF-α和CRP水平均明显升高(均P〈0.01),脂联素水平明显降低(均P〈0.01);治疗前两组患者脂联素、TNF-α和CRP水平,差异无统计学意义(均P〉0.05);在年龄、性别、APACHEII评分等方面两组差异无统计学意义(均P〉0.05)。结论CRRT能通过降低TNF-α和CRP水平及升高脂联素水平,对SAP患者起到较好的治疗作用。
Objective To explore the changes of adiponectin, tumor necrosis factor-α, C-reactive protein as well as the effects of CRRT in patients with severe acute pancreatitis ( SAP ) . Methods 66 patients with SAP Were collected.The patients were divided into control group and CRRT treatment group, the characters of clinical and the Level of adiponectin, tumor necrosis factor-α, C-reactive protein were compared between the two groups. Results the lever of tumor necrosis factor-α, C-reactive protein were significantly higher in control group group than that in CRRT treatment group in day 1 ( both P〈0.05 ) , the lever of adiponectin was significantly lower in control group group than that in CRRT treatment group in day 1 ( bothP〈0.05 ) ; the lever of tumor necrosis factor-α C-reactive protein were significantly higher in control group group than that in CRRT treatment group in day 2 and day 3 ( allP〈0.01 ) , the lever of adiponectin were significantly lower in control group group than that in CRRT treatment group in day 2 and day 3 ( bothP〈0.01 ) ; there is no significant differences between control group and CRRT treatment group in adiponectin, tumor necrosis factor-α, C-reactive protein before treatment ( all P〉 0.05 ) ;there is no significant differences between control group and CRRT treatment group in Age, gender, APACHE II score ( all P〉0.05 ) . Conclusion CRRT can effectively reduce the plasma levels of TNF-α , CRP and Increase the plasma levels of adiponectin in SAP patients, it play a therapeutic effect through changing the cytokine of SAP patients.
出处
《浙江临床医学》
2012年第11期1332-1334,共3页
Zhejiang Clinical Medical Journal
关键词
重症急性胰腺炎脂联素肿瘤坏死因子-α
C反应蛋白
连续性肾替代治疗
Severe acute pancreatitis (SAP) Adiponectin (APN) Tumor necrosis factor-α C-reactive protein Continuous renal replacement therapy ( CRRT )